Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication)
Intest Res. 2018;16(2):178-193.   Published online 2018 Apr 30     DOI: https://doi.org/10.5217/ir.2018.16.2.178
Citations to this article as recorded by Crossref logo
Absence of Oral Opportunistic Infections in Patients with Inflammatory Bowel Disease Receiving Anti-TNF-α and Anti-Integrin-α4β7 Therapy
Ema Saltović, Brankica Mijandrušić-Sinčić, Alen Braut, Ivana Škrobonja, Ella Sever, Irena Glažar, Sonja Pezelj-Ribarić, Miranda Muhvić-Urek
Dentistry Journal.2022; 10(3): 32.     CrossRef
Can visceral adipose tissue and skeletal muscle predict recurrence of newly diagnosed Crohn’s disease in different treatments
Zinan Zhang, Xiaoyu Yu, Ning Fang, Xiuyan Long, Xixian Ruan, Jianing Qiu, Sifan Tao, Pan Gong, Kai Nie, An Li, Xiaoyan Wang, Li Tian
BMC Gastroenterology.2022;[Epub]     CrossRef
Neurological presentations of inflammatory bowel diseases
Yu. O. Shulpekova, V. U. Ablaev, I. V. Damulin
Medical alphabet.2021; (3): 34.     CrossRef
Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional Study
Ido Veisman, Oranit Barzilay, Liora Bruckmayer, Ola Haj-Natour, Uri Kopylov, Rami Eliakim, Shomron Ben-Horin, Bella Ungar
Journal of Clinical Medicine.2021; 10(18): 4265.     CrossRef
Fucose Ameliorates Tritrichomonas sp.-Associated Illness in Antibiotic-Treated Muc2−/− Mice
Kseniya M. Achasova, Elena N. Kozhevnikova, Mariya A. Borisova, Ekaterina A. Litvinova
International Journal of Molecular Sciences.2021; 22(19): 10699.     CrossRef
The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn’s Disease: 4 Years of Global Post-marketing Data
Russell D Cohen, Fatima Bhayat, Aimee Blake, Simon Travis
Journal of Crohn's and Colitis.2020; 14(2): 192.     CrossRef
Chronic Diarrhea in Children: Causes, Mechanisms, Primary Diagnostics and Management
Dmitriy V. Pechkurov, Alena A. Tyazheva
Current Pediatrics.2020; 18(6): 416.     CrossRef
Chronic Diarrhea in Children: Causes, Mechanisms, Primary Diagnostics and Management
Dmitriy V. Pechkurov, Alena A. Tyazheva
Current Pediatrics.2020; 18(6): 416.     CrossRef
Review article: managing the adverse events caused by anti-TNF therapy in inflammatory bowel disease
Uday N. Shivaji, Caroline L. Sharratt, Tom Thomas, Samuel C. L. Smith, Marietta Iacucci, Gordon W. Moran, Subrata Ghosh, Neeraj Bhala
Alimentary Pharmacology & Therapeutics.2019; 49(6): 664.     CrossRef
CYTOMEGALOVIRUS INFECTION IN INFLAMMATORY BOWEL DISEASES
I. L. Khalif, T. L. Alexandrov, L. B. Kisteneva
Koloproktologia.2019; 18(1(67)): 119.     CrossRef
The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: fromin silicotoin vivo
Shian-Ren Lin, Chia-Hsiang Chang, May-Jwan Tsai, Henrich Cheng, Jian-Chyi Chen, Max K. Leong, Ching-Feng Weng
Therapeutic Advances in Chronic Disease.2019; 10: 204062231987530.     CrossRef
A rare case of disseminated histoplasmosis in a patient with Crohn’s disease on immunosuppressive treatment
Bhavesh Bhut, Akshay Kulkarni, Varnika Rai, Vinita Agrawal, Abhai Verma, Manoj Jain, Rungmei S K Marak, Ajai Kumar Dixit, Uday C Ghoshal
Indian Journal of Gastroenterology.2018; 37(5): 472.     CrossRef
The importance of immunization in immune-mediated inflammatory disease cannot be overstated
Sang Hyoung Park
Intestinal Research.2018; 16(3): 325.     CrossRef